{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:30:45Z","timestamp":1794047445197,"version":"4.8.0"},"reference-count":15,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"1","license":[{"start":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T00:00:00Z","timestamp":1689811200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"DOI":"10.3324\/haematol.2023.283203","type":"journal-article","created":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T03:44:59Z","timestamp":1689824699000},"page":"312-317","source":"Crossref","is-referenced-by-count":1,"title":["Optimizing transplantation procedures through identification of prognostic factors in second remission for children with acute myeloid leukemia with no prior history of transplant"],"prefix":"10.3324","volume":"109","author":[{"given":"Hisashi","family":"Ishida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-ichi","family":"Tsujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotoshi","family":"Sakaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohei","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakatsu","family":"Yanagimachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuyoshi","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asahito","family":"Hama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichiro","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maiko","family":"Noguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanobu","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Takita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kana","family":"Washio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Koike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiko","family":"Hashii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Tabuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moeko","family":"Hino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiko","family":"Atsuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2023,7,20]]},"reference":[{"key":"56685","doi-asserted-by":"crossref","unstructured":"Zwaan CM, Kolb EA, Reinhardt D. Collaborative efforts driving progress in pediatric acute myeloid leukemia. J Clin Oncol. 2015; 33(27):2949-2962.","DOI":"10.1200\/JCO.2015.62.8289"},{"key":"56686","doi-asserted-by":"crossref","unstructured":"Hasle H. A critical review of which children with acute myeloid leukaemia need stem cell procedures. Br J Haematol. 2014; 166(1):23-33.","DOI":"10.1111\/bjh.12900"},{"key":"56687","doi-asserted-by":"crossref","unstructured":"Karlsson L, Forestier E, Hasle H. Outcome after intensive reinduction therapy and allogeneic stem cell transplant in paediatric relapsed acute myeloid leukaemia. Br J Haematol. 2017; 178(4):592-602.","DOI":"10.1111\/bjh.14720"},{"key":"56688","doi-asserted-by":"crossref","unstructured":"Egan G, Tasian SK. Relapsed pediatric acute myeloid leukaemia: state-of-the-art in 2023. Haematologica. 2023; 108(9):2275-2288.","DOI":"10.3324\/haematol.2022.281106"},{"key":"56689","doi-asserted-by":"crossref","unstructured":"Atsuta Y. Introduction of Transplant Registry Unified Management Program 2 (TRUMP2): scripts for TRUMP data analyses, part I (variables other than HLA-related data). Int J Hematol. 2016; 103(1):3-10.","DOI":"10.1007\/s12185-015-1894-x"},{"key":"56690","doi-asserted-by":"crossref","unstructured":"Giralt S, Ballen K, Rizzo D. Reduced-Intensity Conditioning Regimen Workshop: defining the dose spectrum. Report of a Workshop Convened by the Center for International Blood and Marrow Transplant Research. Biol Blood Marrow Transplant. 2009; 15(3):367-369.","DOI":"10.1016\/j.bbmt.2008.12.497"},{"key":"56691","doi-asserted-by":"crossref","unstructured":"Creutzig U, van den Heuvel-Eibrink MM, Gibson B. Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel. Blood. 2012; 120(16):3187-3205.","DOI":"10.1182\/blood-2012-03-362608"},{"key":"56692","doi-asserted-by":"crossref","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transplant. 2013; 48(3):452-458.","DOI":"10.1038\/bmt.2012.244"},{"key":"56693","doi-asserted-by":"crossref","unstructured":"Hama A, Taga T, Tomizawa D. Haematopoietic cell transplantation for children with acute megakaryoblastic leukaemia without Down syndrome. Br J Haematol. 2023; 201(4):747-756.","DOI":"10.1111\/bjh.18691"},{"key":"56694","doi-asserted-by":"crossref","unstructured":"De Rooij JDE, Branstetter C, Ma J. Pediatric non-Down syndrome acute megakaryoblastic leukemia is characterized by distinct genomic subsets with varying outcomes. Nat Genet. 2017; 49(3):451-456.","DOI":"10.1038\/ng.3772"},{"key":"56695","doi-asserted-by":"crossref","unstructured":"Lucchini G, Labopin M, Beohou E. Impact of conditioning regimen on outcomes for children with acute myeloid leukemia undergoing transplantation in first complete remission. An analysis on behalf of the Pediatric Disease Working Party of the European Group for Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 2017; 23(3):467-474.","DOI":"10.1016\/j.bbmt.2016.11.022"},{"key":"56696","doi-asserted-by":"crossref","unstructured":"Locatelli F, Masetti R, Rondelli R. Outcome of children with high-risk acute myeloid leukemia given autologous or allogeneic hematopoietic cell transplantation in the aieop AML-2002\/01 study. Bone Marrow Transplant. 2015; 50(2):181-188.","DOI":"10.1038\/bmt.2014.246"},{"key":"56697","doi-asserted-by":"crossref","unstructured":"Beier R, Albert MH, Bader P. Allo-SCT using BU, CY and melphalan for children with AML in second CR. Bone Marrow Transplant. 2013; 48(5):651-656.","DOI":"10.1038\/bmt.2012.204"},{"key":"56698","doi-asserted-by":"crossref","unstructured":"Versluys AB, Boelens JJ, Pronk C. Hematopoietic cell transplant in pediatric acute myeloid leukemia after similar upfront therapy; a comparison of conditioning regimens. Bone Marrow Transplant. 2021; 56(6):1426-1432.","DOI":"10.1038\/s41409-020-01201-w"},{"key":"56699","doi-asserted-by":"crossref","unstructured":"Gorin N-C, Labopin M, Czerw T. Autologous stem cell transplantation for adult acute myelocytic leukemia in first remission-Better outcomes after busulfan and melphalan compared with busulfan and cyclophosphamide: a retrospective study from the Acute Leukemia Working Party of the Europe. Cancer. 2017; 123(5):824-831.","DOI":"10.1002\/cncr.30400"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2023.283203\/75845","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2023.283203\/76465","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/11172\/75845","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:04:30Z","timestamp":1794045870000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2023.283203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,20]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2023.283203","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7,20]]}}}